Skip to content
healthcare.dev

Iclusig

NDC 63020-535, ponatinib hydrochloride, tablet, film coated, from Takeda Pharmaceuticals America, Inc..

Product NDC
63020-535
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203469
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63020-535 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PONATINIB HYDROCHLORIDE15 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
63020-535-306302005353030 TABLET, FILM COATED in 1 BOTTLE (63020-535-30)
63020-535-606302005356060 TABLET, FILM COATED in 1 BOTTLE (63020-535-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/16d804b6-4957-43ee-b18c-3b36ec37c5ac

Use it

Look up 63020-535 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63020-535 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63020-535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.